Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep570 | Endocrine-Related Cancer | ECE2022

Insulinoma in a patient with a crest syndrome

Cornejo Dominguez Jesus Manuel , Gavira Maria Isabel Mateo , Larran Escandon Laura , Rodriguez Maria del Mar Roca , Barea Isabel Torres

Introduction: Insulinomas are pancreatic neuroendocrine tumors (PNET), characterized by insulin hypersecretion syndrome with the development of hypoglycemia. The incidence of the tumor is 3-10 cases per million inhabitants. The average age of onset is 40-50 years old, being more frequent in women. Case Reports: We present a clinical case of a patient with CREST syndrome and difficult-to-control hypoglycemia. Female patient, 81 years old, with a history o...

ea0081ep988 | Thyroid | ECE2022

Prevalence of differentiated thyroid carcinoma on hyperfunctioning or toxic thyroid nodules

Amuedo Dominguez Sandra , De Lara Rodriguez Irene , Lluch Ana R. Romero , Disotuar Suset Duen as , Hospital Juan L. Tirado , Navarro Elena

Background: Autonomic hyperfunctioning thyroid nodules account for approximately 5% to 10% of all thyroid nodules. Compared with non-toxic nodules, hot nodules are traditionally believed to have an exceptionally low malignancy rate, and this has led to recommendations not to perform fine-needle aspiration (FNA) on these lesions, regardless of their size. However, recent studies have questioned the presumed low risk of malignancy in hot nodules, suggesting that the incidence of...

ea0049ep756 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2017

Non-lipidic effects of PCSK9 inhibitors in real life

Gonzalez-Molero Inmaculada , Doulatram Viyu , Dominguez Marta , Torralvo Francisco Sanchez , Garcia Ignacio Ruiz , Olveira Gabriel , Tinahones Francisco

Objective: Analyse possible effects on physical examination, blood count, liver and kidney function, and steroidogenic hormones synthesis. Know the satisfaction of patients with the first injectable treatment for hypercholesterolemia approved in our country.Material and methods: Data were collected from patients with heterozygous familial hypercholesterolemia treated with PCSK9 inhibitors. Clinical, physical and analytical data were collected at baseline...

ea0037ep676 | Pituitary: basic and neuroendocrinology | ECE2015

Placental IGF1R–PI3K/Akt pathway and its relationship to idiopathic birth weight alterations

Lazo-de-la-Vega-Monroy Maria-Luisa , Gonzalez-Dominguez Martha I , Daza-Benitez Leonel , Barbosa-Sabanero Gloria

Introduction: Alterations in foetal growth lead to neonatal health risks and favour metabolic diseases during adult life. Therefore, the study of birth weight determination and its modifications is crucial for metabolic diseases prevention. Placental growth is a key factor in foetal growth. It has been suggested that insulin and the IGF system play an important role in foetal growth and placental development and function. Although, insulin and IGFs in the umbilical cord blood ...

ea0035oc1.3 | Thyroid clinical | ECE2014

Chronic liothyronine (T3) treatment in stable heart failure patients with low T3 syndrome: A randomised, double-blind, cross-over, placebo-controlled intervention study (The LIHFA study)

Holmager Pernille , Schmidt Ulla , Dall Mark Peter , Dominguez Helena , Zerahn Bo , Raymond Ilan , Kistorp Caroline , Nygaard Birte , Faber Jens

Background and aim: Low T3 syndrome is associated with a poor prognosis in patients with chronic heart failure (CHF). It is controversial whether T3 treatment is indicated in CHF. A previous study using intravenous infusion of T3 for 72 h suggested a beneficial effect on cardiac performance.We aimed to evaluate the effect of 13 weeks of T3 treatment in patients with stable CHF on left ventricular ejection fraction (LVEF) compared to placebo.<p class=...

ea0032p288 | Clinical case reports - Thyroid / Others | ECE2013

Clinical case report: male patient with SRY-positive 46,XX testicular disorder of sex development

Dominguez-Lopez Marta , Gonzalez-Molero Inmaculada , Esteva Isabel , Gonzalo-Marin Montserrat , de Adana MSoledad Ruiz , Soriguer Federico

The 46 XX male syndrome (de la Chapelle syndrome or 46,XX testicular disorder of sex development -46,XX testicular DSD-) is a rare phenotype associated with disorder of the sex chromosomes. XX males exist in different clinical categories with ambiguous genitalia or partially to fully mature male genitalia, in combination with complete or incomplete masculinization.Clinical report: We describe the clinical, molecular, and cytogenetic findings of a 26-year...

ea0032p463 | Diabetes | ECE2013

Clinical usefulness of a bolus calculator in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion (CSII)

Dominguez-Lopez Marta , Gonzalez-Molero Mercedes Inmaculaca , Guerrero Inmaculaca , Gonzalez Stella , Adana MSoledad Ruiz de , Soriguer Federico

Objective: One of the major problems related to the use of CSII, or intensive insulin regimens in general, is the calculation of accurate insulin boluses. Abolus calculator incorporated into the insulin pump, estimates the dose of insulin to be administered at the meal on the basis of the following parameters: current blood glucose, grams of carbohydrate in the meal, carbohydrate to-insulin ratio (CIR), insulin sensitivity factors (ISF), target blood glucose and quantity of in...

ea0032p486 | Diabetes | ECE2013

Evaluation of adolescents with type 1 diabetes after transition from paediatric to adult care

Dominguez-Lopez Marta , Gonzalez-Molero Inmaculada , Lopez-Siguero Juan Pedro , Navas MSoledad Ruiz de Adana , Escofet Federico Soriguer

Objective: Our objective in this study was to identify the type of clinical care received by young type 1 diabetic patients who have made the transition from paediatric to adult care, and to assess the metabolic status of the patients. The research aimed to develop a sustainable and coordinated approach to facilitating the transition between diabetes services for adolescents and reveal from the perspective of the adolescents living with type 1 diabetes their experiences surrou...

ea0032p489 | Diabetes | ECE2013

Analysis of the newly diagnosed diabetic patients, one year and five years of evolution, C-peptide, autoinmunity, treatment and metabolic control

Dominguez-Lopez Marta , Fernandez-Arias David , Gonzalez-Molero Inmaculada , Colomo Natalia , Adana Marisol Ruiz de , Soriguer Federico

Objective: We retrospectively analyzed patients with type 1 diabetes onset, attended during the years 2005 and 2006 on the specific query of type 1 DM debut of a tertiary hospital, with initial treatment assessment, at 1 and 5 years evolution.Results: Patients were treated for newly diagnosed DM 1, 25 patients (72% male, 28% female) mean age 23.2 years (14–36), mean BMI: 23.18 (18–33.8%).The clinical presentation included: 88.24% presented with...

ea0029p1085 | Neuroendocrinology | ICEECE2012

Panhypopituitarism treated and untreated with GH: long term evolution of echocardiographic parameters

Arnes J. Garcia , Gonzalez-Molero I. , Lopez M. Dominguez , Marin M. Gonzalo , Penafiel R. , Madero G. Fernandez

Objective: To evaluate the effects of GH on cardiac structure and function of patients with panhypopituitarism.Material and methods: We performed echocardiographic studies of patients with panhypopituitarism treated and not treated with GH at baseline and after 12 years of follow up. We collected clinical and echocardiographic data (systolic and diastolic ventricular diameter (LVEDD and DTSVI), interventricular septum thickness (IVS), left ventricular po...